car-t
Entity, reached from Hormuz.
- Evidence
- 105 documents · 38 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 1 Jan 2026, last seen 8 Oct 2026
- Measured
- 19% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- AllSci News · 2026-10-07 · Caribou Bio halts both CAR-T programs and launches sale process amid funding challenges (opens the source in a new tab)
- Endpoints News · 2026-10-07 · CAR-T biotech Caribou weighs its options after struggling to find funding (opens the source in a new tab)
- Denkstrom · 2026-10-07 · 17,7 Millionen Dollar für neue CAR-T-Studie (opens the source in a new tab)
- Medical Daily · 2026-09-30 · Lupus Patients Stopped Every Immunosuppressant After One Off-the-Shelf CAR-T Dose in Small Trial, but Therapy Remains Experimental (opens the source in a new tab)
- AllSci News · 2026-09-30 · IASO Bio’s BCMA/GPRC5D dual-targeted CAR-T RD140 shows 88.9% response rate in Phase I (opens the source in a new tab)
- PR Newswire · 2026-09-27 · 2026 IMS | IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206 (opens the source in a new tab)
- BioPharma Dive · 2026-09-15 · Cellectis quits CAR-T and pivots to ‘in vivo’ gene editing (opens the source in a new tab)
- Fierce Biotech · 2026-09-07 · BrainChild Bio masterminds $116M series A for CAR-T's pivotal push in pediatric brain cancer (opens the source in a new tab)
- J Gastroenterol · 2026-09-07 · A PRK-armed oncolytic adenovirus drives calreticulin exposure for dendritic cell licensing to prime antitumor CD8⁺ T cells and synergizes with anti-PD-1 or CAR-T therap… (opens the source in a new tab)
- STAT News · 2026-09-05 · STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more (opens the source in a new tab)
1 more on file, counted in the evidence above.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with t-cell (48 documents)seen together
- co-mentioned with fda (44 documents)seen together
- co-mentioned with studie (37 documents)seen together
- co-mentioned with immunotherapy (32 documents)seen together
- co-mentioned with clinical trial (29 documents)seen together
- co-mentioned with car t-cell (27 documents)seen together
- co-mentioned with clinical trials (25 documents)seen together
- co-mentioned with ai (23 documents)seen together
- co-mentioned with solid tumors (22 documents)seen together
- co-mentioned with united states (18 documents)seen together